IBDEI0GQ ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1022,0)
 ;;=FUNCTIONAL RPTING-MOBILITY^7^117
 ;;^UTILITY(U,$J,358.4,1023,0)
 ;;=FUNCTIONAL RPTING-MOTOR SPEECH^8^117
 ;;^UTILITY(U,$J,358.4,1024,0)
 ;;=FUNCTIONAL RPTING-OTH PT/OT PRIM^9^117
 ;;^UTILITY(U,$J,358.4,1025,0)
 ;;=FUNCTIONAL RPTING-OTH PT/OT SUB^10^117
 ;;^UTILITY(U,$J,358.4,1026,0)
 ;;=FUNCTIONAL RPTING-SELF CARE^11^117
 ;;^UTILITY(U,$J,358.4,1027,0)
 ;;=FUNCTIONAL RPTING-SPEECH/LANG COMP^12^117
 ;;^UTILITY(U,$J,358.4,1028,0)
 ;;=FUNCTIONAL RPTING-SPOKEN LANG EXPRESS^13^117
 ;;^UTILITY(U,$J,358.4,1029,0)
 ;;=FUNCTIONAL RPTING-VOICE^14^117
 ;;^UTILITY(U,$J,358.4,1030,0)
 ;;=RECREATION THERAPY DIAGNOSES^1^118
 ;;^UTILITY(U,$J,358.4,1031,0)
 ;;=Primary Diagnosis for RCAT Therapy^1^119
 ;;^UTILITY(U,$J,358.4,1032,0)
 ;;=1-1 THERAPEUTIC PROCEDURES^1^120
 ;;^UTILITY(U,$J,358.4,1033,0)
 ;;=EDUCATION/TRAINING^3^120
 ;;^UTILITY(U,$J,358.4,1034,0)
 ;;=TEAM CONFERENCE^18^120
 ;;^UTILITY(U,$J,358.4,1035,0)
 ;;=ASSESSMENT^2^120
 ;;^UTILITY(U,$J,358.4,1036,0)
 ;;=FAMILY TRAINING^4^120
 ;;^UTILITY(U,$J,358.4,1037,0)
 ;;=SPECIALTY PROCEDURES-INDIVIDUAL^17^120
 ;;^UTILITY(U,$J,358.4,1038,0)
 ;;=FUNCTIONAL RPTING-ATTENTION^5^120
 ;;^UTILITY(U,$J,358.4,1039,0)
 ;;=FUNCTIONAL RPTING-BODY POSITION^6^120
 ;;^UTILITY(U,$J,358.4,1040,0)
 ;;=FUNCTIONAL RPTING-CARRY OBJECTS^7^120
 ;;^UTILITY(U,$J,358.4,1041,0)
 ;;=FUNCTIONAL RPTING-MEMORY^8^120
 ;;^UTILITY(U,$J,358.4,1042,0)
 ;;=FUNCTIONAL RPTING-MOBILITY^9^120
 ;;^UTILITY(U,$J,358.4,1043,0)
 ;;=FUNCTIONAL RPTING-MOTOR SPEECH^10^120
 ;;^UTILITY(U,$J,358.4,1044,0)
 ;;=FUNCTIONAL RPTING-OTH PT/OT PRIM^11^120
 ;;^UTILITY(U,$J,358.4,1045,0)
 ;;=FUNCTIONAL RPTING-OTH PT/OT SUB^12^120
 ;;^UTILITY(U,$J,358.4,1046,0)
 ;;=FUNCTIONAL RPTING-SELF CARE^13^120
 ;;^UTILITY(U,$J,358.4,1047,0)
 ;;=FUNCTIONAL RPTING-SPEECH/LANG COMP^14^120
 ;;^UTILITY(U,$J,358.4,1048,0)
 ;;=FUNCTIONAL RPTING-SPOKEN LANG EXPRESS^15^120
 ;;^UTILITY(U,$J,358.4,1049,0)
 ;;=FUNCTIONAL RPTING-VOICE^16^120
 ;;^UTILITY(U,$J,358.4,1050,0)
 ;;=Primary Diagnosis for RCAT Therapy^1^121
 ;;^UTILITY(U,$J,358.4,1051,0)
 ;;=RECREATION THERAPY DIAGNOSES^1^122
 ;;^UTILITY(U,$J,358.4,1052,0)
 ;;=NEW PATIENT^2^123
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=ESTABLISHED PATIENT^1^123
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=CONSULTATIONS^3^123
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=THERAPY MODALITIES/PROCEDURES^2^124
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=INJECTIONS/DRUGS^6^124
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=ORTHOTIC DEVICES^9^124
 ;;^UTILITY(U,$J,358.4,1058,0)
 ;;=KINESIOTHERAPY^7^124
 ;;^UTILITY(U,$J,358.4,1059,0)
 ;;=THERAPY EVALUATIONS^1^124
 ;;^UTILITY(U,$J,358.4,1060,0)
 ;;=WOUND CARE^11^124
 ;;^UTILITY(U,$J,358.4,1061,0)
 ;;=CARDIAC REHAB^3^124
 ;;^UTILITY(U,$J,358.4,1062,0)
 ;;=EDUCATION/TRAINING^4^124
 ;;^UTILITY(U,$J,358.4,1063,0)
 ;;=HOME THERAPY SERVICES^5^124
 ;;^UTILITY(U,$J,358.4,1064,0)
 ;;=NEUROMUSCULAR TESTING^8^124
 ;;^UTILITY(U,$J,358.4,1065,0)
 ;;=TEAM CONFERENCE^10^124
 ;;^UTILITY(U,$J,358.4,1066,0)
 ;;=FUNCTIONAL RPTING BODY POSITION^12^124
 ;;^UTILITY(U,$J,358.4,1067,0)
 ;;=FUNCTIONAL RPTING CARRY OBJECTS^13^124
 ;;^UTILITY(U,$J,358.4,1068,0)
 ;;=FUNCTIONAL RPTING MOBILITY^14^124
 ;;^UTILITY(U,$J,358.4,1069,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT PRI^15^124
 ;;^UTILITY(U,$J,358.4,1070,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT SUB^16^124
 ;;^UTILITY(U,$J,358.4,1071,0)
 ;;=FUNCTIONAL RPTING SELF CARE^17^124
 ;;^UTILITY(U,$J,358.4,1072,0)
 ;;=PRIMARY DIAGNOSES^1^125
 ;;^UTILITY(U,$J,358.4,1073,0)
 ;;=V CODES ^1^126
 ;;^UTILITY(U,$J,358.4,1074,0)
 ;;=AMPUTATION STATUS^2^126
 ;;^UTILITY(U,$J,358.4,1075,0)
 ;;=BRAIN DISORDERS^3^126
 ;;^UTILITY(U,$J,358.4,1076,0)
 ;;=CARDIOPULMONARY^4^126
 ;;^UTILITY(U,$J,358.4,1077,0)
 ;;=COMPLICATION DUE TO^5^126
 ;;^UTILITY(U,$J,358.4,1078,0)
 ;;=FRACTURES-LATE EFFECTS^6^126
 ;;^UTILITY(U,$J,358.4,1079,0)
 ;;=MENTAL DISORDERS^7^126
 ;;^UTILITY(U,$J,358.4,1080,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^8^126
 ;;^UTILITY(U,$J,358.4,1081,0)
 ;;=TERTIARY DX-TBI CODES^10^126
 ;;^UTILITY(U,$J,358.4,1082,0)
 ;;=QUATERNARY DX-POLYTRAUMA/TBI V-CODE^9^126
 ;;^UTILITY(U,$J,358.4,1083,0)
 ;;=ASPIRATION/INJECTION^1^127
 ;;^UTILITY(U,$J,358.4,1084,0)
 ;;=INJECTION MEDICATIONS^2^127
 ;;^UTILITY(U,$J,358.4,1085,0)
 ;;=NEW PATIENT^2^128
 ;;^UTILITY(U,$J,358.4,1086,0)
 ;;=ESTABLISHED PATIENT^1^128
 ;;^UTILITY(U,$J,358.4,1087,0)
 ;;=CONSULTATIONS^3^128
 ;;^UTILITY(U,$J,358.4,1088,0)
 ;;=INFLAMMATORY CONDITIONS^8^129
 ;;^UTILITY(U,$J,358.4,1089,0)
 ;;=OSTEOARTHRITIS^14^129
 ;;^UTILITY(U,$J,358.4,1090,0)
 ;;=SPINE DISORDERS^19^129
 ;;^UTILITY(U,$J,358.4,1091,0)
 ;;=INTERNAL DERANGEMENT OF KNEE^9^129
 ;;^UTILITY(U,$J,358.4,1092,0)
 ;;=JOINT DISORDERS^10^129
 ;;^UTILITY(U,$J,358.4,1093,0)
 ;;=TENDINITIS & BURSITIS^20^129
 ;;^UTILITY(U,$J,358.4,1094,0)
 ;;=OTHER INFLAMMATORY^17^129
 ;;^UTILITY(U,$J,358.4,1095,0)
 ;;=INFECTIONS^7^129
 ;;^UTILITY(U,$J,358.4,1096,0)
 ;;=VASCULAR DIORDERS^22^129
 ;;^UTILITY(U,$J,358.4,1097,0)
 ;;=MISCELLANEOUS^11^129
 ;;^UTILITY(U,$J,358.4,1098,0)
 ;;=VASCULITIS CONDITIONS^21^129
 ;;^UTILITY(U,$J,358.4,1099,0)
 ;;=CRYSTAL ARTHROPATHIES^5^129
 ;;^UTILITY(U,$J,358.4,1100,0)
 ;;=OSTEOPOROSIS^16^129
 ;;^UTILITY(U,$J,358.4,1101,0)
 ;;=ARTHROPATHIES^2^129
 ;;^UTILITY(U,$J,358.4,1102,0)
 ;;=OSTEOMYELITIS^15^129
 ;;^UTILITY(U,$J,358.4,1103,0)
 ;;=PYOGENIC ARTHRITIS^18^129
 ;;^UTILITY(U,$J,358.4,1104,0)
 ;;=DIABETES ^6^129
 ;;^UTILITY(U,$J,358.4,1105,0)
 ;;=COMMON DIAGNOSES^1^129
 ;;^UTILITY(U,$J,358.4,1106,0)
 ;;=MUSCULOSKELETAL^12^129
 ;;^UTILITY(U,$J,358.4,1107,0)
 ;;=NERVOUS SYSTEM^13^129
 ;;^UTILITY(U,$J,358.4,1108,0)
 ;;=CIRCULATORY^4^129
 ;;^UTILITY(U,$J,358.4,1109,0)
 ;;=BLOOD DISORDERS^3^129
 ;;^UTILITY(U,$J,358.4,1110,0)
 ;;=BLANK^0^129
 ;;^UTILITY(U,$J,358.4,1111,0)
 ;;=VACCINATIONS^12^130
 ;;^UTILITY(U,$J,358.4,1112,0)
 ;;=INJECTION^6^130
 ;;^UTILITY(U,$J,358.4,1113,0)
 ;;=EDUCATION/TRAINING^2^130
 ;;^UTILITY(U,$J,358.4,1114,0)
 ;;=COUNSELING^1^130
 ;;^UTILITY(U,$J,358.4,1115,0)
 ;;=EVALUATIONS^3^130
 ;;^UTILITY(U,$J,358.4,1116,0)
 ;;=SPINAL INJECTION CODES^8^130
 ;;^UTILITY(U,$J,358.4,1117,0)
 ;;=SUPPLIES^9^130
 ;;^UTILITY(U,$J,358.4,1118,0)
 ;;=TREATMENT PROCEDURES^10^130
 ;;^UTILITY(U,$J,358.4,1119,0)
 ;;=TRIGGER POINT INJECTIONS^11^130
 ;;^UTILITY(U,$J,358.4,1120,0)
 ;;=HOME VISIT-ESTABLISHED PT^4^130
 ;;^UTILITY(U,$J,358.4,1121,0)
 ;;=HOME VISIT-NEW PT^5^130
 ;;^UTILITY(U,$J,358.4,1122,0)
 ;;=ON-LINE MEDICAL EVAL^7^130
 ;;^UTILITY(U,$J,358.4,1123,0)
 ;;=OTHER/MISC DIAGNOSES^8^131
 ;;^UTILITY(U,$J,358.4,1124,0)
 ;;="E" CODES-SECONDARY ONLY^7^131
 ;;^UTILITY(U,$J,358.4,1125,0)
 ;;="D" DIAGNOSIS^6^131
 ;;^UTILITY(U,$J,358.4,1126,0)
 ;;="C" DIAGNOSIS^5^131
 ;;^UTILITY(U,$J,358.4,1127,0)
 ;;="B" DIAGNOSIS^4^131
 ;;^UTILITY(U,$J,358.4,1128,0)
 ;;="A" DIAGNOSIS^3^131
 ;;^UTILITY(U,$J,358.4,1129,0)
 ;;=PARAPLEGIA^1^131
 ;;^UTILITY(U,$J,358.4,1130,0)
 ;;=QUADRAPLEGIA^2^131
 ;;^UTILITY(U,$J,358.4,1131,0)
 ;;=NEW PT-OFFICE^3^132
 ;;^UTILITY(U,$J,358.4,1132,0)
 ;;=ESTABLISHED PT-OFFICE^1^132
 ;;^UTILITY(U,$J,358.4,1133,0)
 ;;=CONSULTATIONS^5^132
 ;;^UTILITY(U,$J,358.4,1134,0)
 ;;=SCREENING FOR MENTAL/DEVELOPMENT^25^133
 ;;^UTILITY(U,$J,358.4,1135,0)
 ;;=PERSONAL HX OF MALIGNANCY^22^133
 ;;^UTILITY(U,$J,358.4,1136,0)
 ;;=ACQUIRED ABSENCE OF ORGAN^2^133
 ;;^UTILITY(U,$J,358.4,1137,0)
 ;;=PERSONS SEEKING CONSULT^23^133
 ;;^UTILITY(U,$J,358.4,1138,0)
 ;;=FAMILY CIRCUMSTANCES^9^133
 ;;^UTILITY(U,$J,358.4,1139,0)
 ;;=FAMILY HX OF MALIGNANCY^11^133
 ;;^UTILITY(U,$J,358.4,1140,0)
 ;;=FAMILY HX OF CHR DISABILITY^10^133
 ;;^UTILITY(U,$J,358.4,1141,0)
 ;;=PERSONAL HX OF HAZARDS TO HEALTH^21^133
 ;;^UTILITY(U,$J,358.4,1142,0)
 ;;=FAMILY HX OF SPECIFIC CONDITION^13^133
 ;;^UTILITY(U,$J,358.4,1143,0)
 ;;=FAMILY HX OF OTHER CONDITION^12^133
 ;;^UTILITY(U,$J,358.4,1144,0)
 ;;=MENTAL AND BEHAVIORAL PROBLEMS^15^133
 ;;^UTILITY(U,$J,358.4,1145,0)
 ;;=ORGAN OR TISSUE REPLACED^16^133
 ;;^UTILITY(U,$J,358.4,1146,0)
 ;;=PERSONAL HX OF CERTAIN DX^20^133
 ;;^UTILITY(U,$J,358.4,1147,0)
 ;;=ARTIFICIAL OPENING STATUS^3^133
 ;;^UTILITY(U,$J,358.4,1148,0)
 ;;=OTHER POSTSURGICAL STATES^17^133
 ;;^UTILITY(U,$J,358.4,1149,0)
 ;;=PALLATIVE CARE^19^133
 ;;^UTILITY(U,$J,358.4,1150,0)
 ;;=DEPENDENCE ON MACHINES^8^133
 ;;^UTILITY(U,$J,358.4,1151,0)
 ;;=PROBLEMS RELATED TO LIFESTYLE^24^133
 ;;^UTILITY(U,$J,358.4,1152,0)
 ;;=ADMINISTRATIVE PURPOSES^1^133
 ;;^UTILITY(U,$J,358.4,1153,0)
 ;;=CONTACT W/ COMMUNICABLE DISEASES^7^133
 ;;^UTILITY(U,$J,358.4,1154,0)
 ;;=CARRIER OF INFECTIOUS DX^5^133
 ;;^UTILITY(U,$J,358.4,1155,0)
 ;;=ASYMPTOMATIC HIV INFECTION^4^133
 ;;^UTILITY(U,$J,358.4,1156,0)
 ;;=CONDITIONS INFLUENCING HEALTH^6^133
 ;;^UTILITY(U,$J,358.4,1157,0)
 ;;=HOUSING & ECONOMIC CIRCUMSTANCES^14^133
 ;;^UTILITY(U,$J,358.4,1158,0)
 ;;=OTHER PSYCHOSOCIAL CIRCUMSTANCES^18^133
 ;;^UTILITY(U,$J,358.4,1159,0)
 ;;=OTHER^7^134
 ;;^UTILITY(U,$J,358.4,1160,0)
 ;;=CASE MANAGEMENT SERVICES^1^134
 ;;^UTILITY(U,$J,358.4,1161,0)
 ;;=HOME HEATLH VISIT^5^134
 ;;^UTILITY(U,$J,358.4,1162,0)
 ;;=COMMUNITY RESIDENTIAL CARE^2^134
 ;;^UTILITY(U,$J,358.4,1163,0)
 ;;=SMOKING/TOBACCO USE CESSATION^8^134
 ;;^UTILITY(U,$J,358.4,1164,0)
 ;;=NON-EMER PATIENT TRANSPORT^6^134
 ;;^UTILITY(U,$J,358.4,1165,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^4^134
 ;;^UTILITY(U,$J,358.4,1166,0)
 ;;=EDUCATION/TRAINING^3^134
 ;;^UTILITY(U,$J,358.4,1167,0)
 ;;=COGNITIVE DISORDERS^1^135
 ;;^UTILITY(U,$J,358.4,1168,0)
 ;;=DEVELOPMENTAL DISORDERS^2^135
 ;;^UTILITY(U,$J,358.4,1169,0)
 ;;=LATE EFFECTS OF CEREBROVASCULAR DIS^5^135
 ;;^UTILITY(U,$J,358.4,1170,0)
 ;;=VOCAL FOLD DISORDER^9^135
 ;;^UTILITY(U,$J,358.4,1171,0)
 ;;=OTHER SPEECH DISORDERS^6^135
 ;;^UTILITY(U,$J,358.4,1172,0)
 ;;=HISTORY OF MALIGNANCY^3^135
 ;;^UTILITY(U,$J,358.4,1173,0)
 ;;=PSYCHOGENIC^7^135
 ;;^UTILITY(U,$J,358.4,1174,0)
 ;;=SWALLOWING DISORDER^8^135
